Armstrong A - Search Results

1

Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer.

Zhao Z, Patel PA, Slatnick L, Sitthi-Amorn A, Bielamowicz KJ, Nunez FA, Walsh AM, Hess J, Rossoff J, Elgarten C, Myers R, Saab R, Basbous M, Mccormick M, Aftandilian C, Richards R, Nessle CN, Tribble AC, Sheth Bhutada JK, Coven SL, Runco D, Wilkes J, Gurunathan A, Guinipero T, Belsky JA, Lee K, Wong V, Malhotra M, Armstrong A, Jerkins LP, Cross SJ, Fisher L, Stein MT, Wu NL, Yi T, Orgel E, Haeusler GM, Wolf J, Demedis JM, Miller TP, Esbenshade AJ. Zhao Z, et al. Among authors: armstrong a. J Clin Oncol. 2024 Mar 1;42(7):832-841. doi: 10.1200/JCO.23.01814. Epub 2023 Dec 7. J Clin Oncol. 2024. PMID: 38060973

2

Cell-free DNA next-generation sequencing successfully detects infectious pathogens in pediatric oncology and hematopoietic stem cell transplant patients at risk for invasive fungal disease.

Armstrong AE, Rossoff J, Hollemon D, Hong DK, Muller WJ, Chaudhury S. Armstrong AE, et al. Pediatr Blood Cancer. 2019 Jul;66(7):e27734. doi: 10.1002/pbc.27734. Epub 2019 Apr 2. Pediatr Blood Cancer. 2019. PMID: 30941906 Clinical Trial.

3

Noninvasive Diagnosis of Infection Using Plasma Next-Generation Sequencing: A Single-Center Experience.

Rossoff J, Chaudhury S, Soneji M, Patel SJ, Kwon S, Armstrong A, Muller WJ. Rossoff J, et al. Among authors: armstrong a. Open Forum Infect Dis. 2019 Aug 1;6(8):ofz327. doi: 10.1093/ofid/ofz327. Open Forum Infect Dis. 2019. PMID: 31375834 Free PMC article.

4

The Impact of High-resolution HLA-A, HLA-B, HLA-C, and HLA-DRB1 on Transplant-related Outcomes in Single-unit Umbilical Cord Blood Transplantation in Pediatric Patients.

Armstrong AE, Smyth E, Helenowski IB, Tse WT, Duerst RE, Schneiderman J, Kletzel M, Chaudhury S. Armstrong AE, et al. J Pediatr Hematol Oncol. 2017 Jan;39(1):26-32. doi: 10.1097/MPH.0000000000000690. J Pediatr Hematol Oncol. 2017. PMID: 27820121

5

Loss of Chromosome 3q Is a Prognostic Marker in Fusion-Negative Rhabdomyosarcoma.

Dehner CA, Bell RC, Cao Y, He K, Chrisinger JSA, Armstrong AE, Yohe M, Shern J, Hirbe AC. Dehner CA, et al. Among authors: armstrong ae. JCO Precis Oncol. 2023 Sep;7:e2300037. doi: 10.1200/PO.23.00037. JCO Precis Oncol. 2023. PMID: 37738543 Free PMC article.

6

Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG).

Desai AV, Robinson GW, Gauvain K, Basu EM, Macy ME, Maese L, Whipple NS, Sabnis AJ, Foster JH, Shusterman S, Yoon J, Weiss BD, Abdelbaki MS, Armstrong AE, Cash T, Pratilas CA, Corradini N, Marshall LV, Farid-Kapadia M, Chohan S, Devlin C, Meneses-Lorente G, Cardenas A, Hutchinson KE, Bergthold G, Caron H, Chow Maneval E, Gajjar A, Fox E. Desai AV, et al. Among authors: armstrong ae. Neuro Oncol. 2022 Oct 3;24(10):1776-1789. doi: 10.1093/neuonc/noac087. Neuro Oncol. 2022. PMID: 35395680 Free PMC article. Clinical Trial.

7

Irinotecan and temozolomide for treatment of neuroblastoma in a patient with renal failure on hemodialysis.

Armstrong AE, Dargart J, Reichek J, Walterhouse DO, Matossian D, Cohn RA, Gosiengfiao Y. Armstrong AE, et al. Pediatr Blood Cancer. 2014 May;61(5):949-50. doi: 10.1002/pbc.24869. Epub 2013 Nov 23. Pediatr Blood Cancer. 2014. PMID: 24273036

8

Sclerosing Epithelioid Fibrosarcoma of the Liver in a Pediatric Patient.

Armstrong A, Boulos F, Kulkarni S, Stoll J, Doyle MBM, Khan A, He M. Armstrong A, et al. Pediatr Dev Pathol. 2023 Mar-Apr;26(2):153-160. doi: 10.1177/10935266221146378. Epub 2023 Feb 6. Pediatr Dev Pathol. 2023. PMID: 36748108

9

Late Effects in Pediatric High-risk Neuroblastoma Survivors After Intensive Induction Chemotherapy Followed by Myeloablative Consolidation Chemotherapy and Triple Autologous Stem Cell Transplants.

Armstrong AE, Danner-Koptik K, Golden S, Schneiderman J, Kletzel M, Reichek J, Gosiengfiao Y. Armstrong AE, et al. J Pediatr Hematol Oncol. 2018 Jan;40(1):31-35. doi: 10.1097/MPH.0000000000000848. J Pediatr Hematol Oncol. 2018. PMID: 28538090

10

Genetic Characterization, Current Model Systems and Prognostic Stratification in PAX Fusion-Negative vs. PAX Fusion-Positive Rhabdomyosarcoma.

Dehner CA, Armstrong AE, Yohe M, Shern JF, Hirbe AC. Dehner CA, et al. Among authors: armstrong ae. Genes (Basel). 2021 Sep 25;12(10):1500. doi: 10.3390/genes12101500. Genes (Basel). 2021. PMID: 34680895 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,163 results

Search Page